Basel Medical Group (BMGL) said Monday it closed an initial public offering of 2.2 million shares at $4 each to raise $8.8 million in gross proceeds.
The Singapore-based medical services provider has granted the underwriters a 45-day option to purchase up to 330,750 additional shares.
Basel Medical plans to use the net proceeds for potential mergers and acquisitions, and business expansion, among other things.
The shares began trading Feb. 25 on Nasdaq under the ticker symbol "BMGL."
The company said it has registered for the resale of up to 2 million shares by certain shareholders.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。